Anaphylaxis is an acute, severe, and potentially life-threatening allergic reaction. A single shot of epinephrine can dramatically improve outcomes for anaphylaxis; however, epinephrine auto injectors can cost hundreds of dollars are not readily available in low- and middle-income countries. EpiForAll is an affordable epinephrine auto-injector used to treat anaphylaxis. EpiForAll revolutionizes auto-injectors by using readily available, low cost epinephrine ampules. EpiForAll won the 2017 Hollomon Health Innovation Challenge and continues to be developed at UW.